# Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman

> **NCT04197349** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 96 (actual)

## Conditions studied

- Migraine

## Interventions

- **BIOLOGICAL:** ALD1910
- **BIOLOGICAL:** Sumatriptan
- **BIOLOGICAL:** ALD1910

## Key facts

- **NCT ID:** NCT04197349
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-24
- **Primary completion:** 2020-08-19
- **Final completion:** 2020-08-19
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2020-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04197349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04197349, "Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04197349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*